If your lab already has library prep dialed in, Admera’s sequencing-only service gives you a fast, flexible path to high-quality data without sacrificing control. Submit your prepared libraries and leverage our expert QC, optimized pooling strategies, and access to leading platforms including NovaSeq X Plus, NextSeq 1000, MiSeq, PacBio Revio, and DNBSEQ.

In this guide, we break down everything you need to know about submitting libraries to Admera, from choosing the right sequencing platform and understanding cost drivers to navigating sample QC and data delivery. Whether you're running large-scale WGS, targeted panels, RNA-seq, or long-read applications, we’ll help you maximize data quality, turnaround time, and cost efficiency.

Whole genome sequencing is foundational to modern research, yet short-read approaches can miss complex, structural, and context-dependent regions of the genome. High-fidelity long-read WGS enables direct observations of structural variants, haplotypes, and genomic context, providing the clarity needed for confident biological and translational insights.

RNA sequencing has revolutionized transcriptomics research, but success depends on mastering every step from sample collection to data analysis. This comprehensive guide walks you through the entire RNA-Seq workflow, starting with the critical foundation of RNA extraction and comparing leading kits from Qiagen, Omega, Promega, Zymo, and BioEcho. Learn when to choose between Illumina short-read sequencing for quantification and PacBio Iso-Seq for complete isoform characterization. Discover optimal library preparation strategies including polyA selection, rRNA depletion, and specialized protocols for small RNA and circular RNA. Whether you're planning your first experiment or optimizing current protocols, this guide provides the technical specifications, quality control benchmarks, and practical insights needed to generate high-quality, biologically meaningful data.

Admera Health and Old Dominion University are advancing Alzheimer’s research through a grant-funded collaboration that combines generative AI, single-cell genomics, and explainable bioinformatics.

Choosing the right CRO can feel overwhelming. Our guide breaks down what researchers should look for—from technical capabilities and regulatory compliance to project communication and true cost. Learn why a U.S.-based, CLIA/CAP-certified partner like Admera Health can streamline your genomics workflows and support your research with confidence.

Discover how long-read sequencing technology unlocks complete molecular data for biomarker discovery, gene editing (CRISPR), and optimizing antibody/RNA therapeutics.

Discover how PacBio Revio long-read sequencing and Iso-Seq enable full-length transcript analysis, accurate isoform detection, alternative splicing characterization, and fusion transcript discovery, overcoming the limitations of short-read RNA sequencing for advanced transcriptomics research.

Discover how to choose between short-read and long-read sequencing for your genomics project. Compare cost, resolution, and hybrid strategies to maximize data clarity and efficiency with Admera Health.

The genome is the blueprint, but the epigenome tells it how to be read. Chemical modifications like DNA methylation and histone changes act as switches that influence health, development, and disease.

Admera Health provides advanced epigenomic sequencing services—from WGBS and EM-seq to Targeted Methyl-seq, ChIP-seq, and CUT&RUN—delivering reliable results even from challenging samples. Partner with us to unlock the next layer of genetic discovery.

Thinking about starting a spatial transcriptomics project?
Explore key considerations for choosing the right platform, preparing your samples, and planning your analysis to generate high-quality, spatially resolved gene expression data.

Admera Health partners with top Certified Service Providers to deliver cutting-edge genomics with precision, reliability, and innovation—empowering breakthroughs that move science forward.

Drug discovery is long, costly, and often slowed by sample loss that compromises NGS data. Admera Health provides expert support and advanced lab services to help biopharma accelerate discoveries with reliable, high-quality results.

Significant nucleic acid sample loss during extraction often bottlenecks Next-Generation Sequencing (NGS), compromising data quality and delaying discoveries. Admera Health intimately understands this challenge, which is why we're thrilled to partner with BioEcho, innovators of the revolutionary EchoLUTION™ nucleic acid purification technology. This strategic alliance ensures clients achieve higher yields and more robust NGS results right from the first step of their research.

Proteomics is revolutionizing biological discovery by providing real-time insights into protein function, disease mechanisms, and biomarker identification. Explore how proteomics enhances multi-omics research by revealing functional protein insights for biomarker discovery, drug target validation, and disease research.

Metabolomics provides a dynamic snapshot of cellular activity, capturing how metabolites reveal the intricate dance of metabolism and environment. Paired with genomics and transcriptomics, this comprehensive approach unlocks unparalleled insights into disease mechanisms, biomarkers, drug response, and microbiome-host interactions. Admera Health bridges the gap between these layers, offering robust NGS services to enhance multi-omics integration, paving the way for impactful discoveries.

Transform your research with single-cell sequencing. Discover rare cells & complex biology at high resolution. Learn how single-cell sequencing can support diverse research applications from immunology to cancer research